SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-012571 to P3 Health Partners Inc. (PIII, PIIIW) (CIK 0001832511) (PIII)

P3 Health Partners Inc. (PIII, PIIIW) (CIK 0001832511)
Date: Nov. 16, 2023 · CIK: 0001832511 · Accession: 0000000000-23-012571

AI Filing Summary & Sentiment

File numbers found in text: 333-275457

Date
November 16, 2023
Author
Not clearly detected
Form
UPLOAD
Company
P3 Health Partners Inc. (PIII, PIIIW) (CIK 0001832511)

Letter

United States securities and exchange commission logo November 16, 2023 Sherif Abdou Chief Executive Officer P3 Health Partners Inc. 2370 Corporate Circle, Suite 300 Henderson, NV 89074 Re:P3 Health Partners Inc. Registration Statement on Form S-3 Filed November 9, 2023 File No. 333-275457 Dear Sherif Abdou: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Lisa Martin, Esq.

Show Raw Text
United States securities and exchange commission logo
November 16, 2023
Sherif Abdou
Chief Executive Officer
P3 Health Partners Inc.
2370 Corporate Circle, Suite 300
Henderson, NV 89074
Re:P3 Health Partners Inc.
Registration Statement on Form S-3
Filed November 9, 2023
File No. 333-275457
Dear Sherif Abdou:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Lisa Martin, Esq.